BioAdaptives, Inc. (OTC: BDPT) has announced that MyndRenew, the nighttime component of its MyndSystem cognitive health platform, has achieved TruShield Certified status. This certification confirms that MyndRenew complies with anti-doping standards established by the World Anti-Doping Agency (WADA) and the Ultimate Fighting Championship (UFC). The announcement follows the previously certified MyndMed daytime formula, meaning that the entire MyndSystem platform is now a fully WADA-compliant 24/7 cognitive performance and recovery system for professional athletes.
The TruShield certification is significant for BioAdaptives as it strengthens the company's position in the competitive sports nutrition market. By meeting stringent anti-doping requirements, MyndSystem becomes a viable option for professional athletes who need to ensure that any supplements they use do not contain prohibited substances. This compliance can facilitate adoption among athletes and sports organizations, potentially opening doors for partnerships and endorsements.
According to BioAdaptives, the certification could enhance commercialization opportunities and strategic partnerships. The company is targeting not only professional athletes but also executives and active seniors who are interested in cognitive health and performance. With MyndSystem now fully certified, BioAdaptives expects broader market adoption as it continues to expand the platform.
The MyndSystem platform is designed to support cognitive function around the clock. MyndMed is the daytime component, while MyndRenew focuses on nighttime recovery. Together, they aim to provide a comprehensive approach to cognitive health, leveraging research on nutrition, adaptogens, and cellular health.
BioAdaptives develops and markets science-based health and wellness products for both humans and animals. The company's formulations are grounded in published research, with an emphasis on supporting normal physiological function. This milestone with MyndRenew represents a step forward in bringing evidence-based supplements to a market that increasingly values transparency and rigorous testing.
For more information about BioAdaptives and its products, visit the company's website at www.bioadaptives.com. The full press release is available at https://ibn.fm/JNHRs.
